TrialJournal for immunotherapy of cancer2026

Randomized phase II trial of nivolumab and ipilimumab with or without stereotactic body radiation therapy in patients with metastatic castration-resistant prostate cancer: the CheckPRO, CA209-8TY trial.

Rikke Løvendahl Eefsen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.